Of clinical interest, GDF15 levels were associated with an increased risk of recurrent adenoma 25, and higher GDF15 levels in serum have been correlated with poor prognosis in cancer patients 26, 27, 28, 29. This evidence concerns the gene GDF15 and adenoma.